K T Park

873 total citations · 1 hit paper
12 papers, 610 citations indexed

About

K T Park is a scholar working on Genetics, Epidemiology and Surgery. According to data from OpenAlex, K T Park has authored 12 papers receiving a total of 610 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Genetics, 9 papers in Epidemiology and 5 papers in Surgery. Recurrent topics in K T Park's work include Inflammatory Bowel Disease (11 papers), Microscopic Colitis (9 papers) and Eosinophilic Esophagitis (2 papers). K T Park is often cited by papers focused on Inflammatory Bowel Disease (11 papers), Microscopic Colitis (9 papers) and Eosinophilic Esophagitis (2 papers). K T Park collaborates with scholars based in United States and Canada. K T Park's co-authors include Dorsey Bass, David T. Rubin, Orna Ehrlich, Miguel Regueiro, Nicole Engel-Nitz, John I. Allen, Eva Szigethy, Sandra C. Kim, Rachel Lawton and Sean M. Murphy and has published in prestigious journals such as The American Journal of Gastroenterology, Digestive Diseases and Sciences and Inflammatory Bowel Diseases.

In The Last Decade

K T Park

12 papers receiving 602 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The Cost of Inflammatory Bowel Disease: An Initiative From the Crohn’s & Colitis Foundation

2019 313 citations K T Park, Orna Ehrlich et al. Inflammatory Bowel Diseases profile →

Peers

Countries citing papers authored by K T Park

Since Specialization

Citations

This map shows the geographic impact of K T Park's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by K T Park with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites K T Park more than expected).

Fields of papers citing papers by K T Park

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by K T Park. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by K T Park. The network helps show where K T Park may publish in the future.

Co-authorship network of co-authors of K T Park

This figure shows the co-authorship network connecting the top 25 collaborators of K T Park. A scholar is included among the top collaborators of K T Park based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with K T Park. K T Park is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

12 of 12 papers shown

#	Work	Indexed citations
1	Clinical Practice Survey of Repeat Endoscopy in Pediatric Inflammatory Bowel Disease in North America 2021 ·Journal of Pediatric Gastroenterology and Nutrition ·Jonathan Moses, (unknown), (unknown), (unknown), Sarah Delozier, Sandeep K. Gupta, Norelle R. Reilly, K T Park, Joseph A. Picoraro	2
2	The Clinical Accuracy of the BÜHLMANN fCAL ELISA in the Differentiation of Inflammatory Bowel Disease From Irritable Bowel Syndrome: A Multicenter Prospective Case–Control Study 2019 ·Crohn s & Colitis 360 ·Jeffrey Berinstein, Calen A. Steiner, Athos Bousvaros, Felix Tiongco, Eugene Greenberg, Robert Hardi, Anthony Lembo, Keith Friedenberg, Shahriar Sedghi, (unknown), (unknown), (unknown), Razvan Arsenescu, K T Park, Peter Kupchak, (unknown), (unknown), Peter Higgins	3
3	The Cost of Inflammatory Bowel Disease: An Initiative From the Crohn’s & Colitis Foundation breakdown → 2019 ·Inflammatory Bowel Diseases ·K T Park, Orna Ehrlich, John I. Allen, (unknown), Eva Szigethy, (unknown), Sandra C. Kim, Rachel Lawton, Sean M. Murphy, Miguel Regueiro, David T. Rubin, Nicole Engel-Nitz, Caren Heller	313
4	Pediatric Inflammatory Bowel Disease Clinical Innovations Meeting of the Crohn’s & Colitis Foundation: Charting the Future of Pediatric IBD 2018 ·Inflammatory Bowel Diseases ·Joseph A. Picoraro, Dale Lee, Caren Heller, Alandra Weaver, Jeffrey S. Hyams, Laurie S. Conklin, Anthony Otley, David Ziring, Subra Kugathasan, Joel R. Rosh, Andrew E. Mulberg, Lee A. Denson, Michael D. Kappelman, Andrew B. Grossman, Athos Bousvaros, K T Park	6
5	Depression and Health Care Use in Patients With Inflammatory Bowel Disease 2018 ·Journal of Crohn s and Colitis ·Jessie J. Wong, Lindsay A. Sceats, (unknown), Anava Wren, Zachary M. Sellers, Berkeley N. Limketkai, Rachel Bensen, Cindy Kin, K T Park	28
6	A Mobile Infliximab Dosing Calculator for Therapy Optimization in Inflammatory Bowel Disease 2018 ·Inflammatory Bowel Diseases ·(unknown), Adam Frymoyer, (unknown), Helen H. Yu, Dorsey Bass, K T Park	8
7	Diet to the Rescue: Cessation of Pharmacotherapy After Initiation of Exclusive Enteral Nutrition (EEN) Followed by Strict and Liberalized Specific Carbohydrate Diet (SCD) in Crohn’s Disease 2017 ·Digestive Diseases and Sciences ·(unknown), (unknown), (unknown), (unknown), K T Park	4
8	Cost-effectiveness of adalimumab, infliximab or vedolizumab as first-line biological therapy in moderate-to-severe ulcerative colitis 2016 ·BMJ Open Gastroenterology ·(unknown), Berkeley N. Limketkai, K T Park	42
9	Health Insurance Paid Costs and Drivers of Costs for Patients With Crohn’s Disease in the United States 2015 ·The American Journal of Gastroenterology ·K T Park, Richard B. Colletti, David T. Rubin, Bal Krishan Sharma, (unknown), Andrew Krueger	68
10	Cost‐effectiveness Analysis of Adjunct VSL#3 Therapy Versus Standard Medical Therapy in Pediatric Ulcerative Colitis 2011 ·Journal of Pediatric Gastroenterology and Nutrition ·K T Park, (unknown), (unknown), Anita Honkanen, Dorsey Bass, Alan M. Garber	8
11	The use of Omegaven in treating parenteral nutrition-associated liver disease 2011 ·Journal of Perinatology ·K T Park, (unknown), John A. Kerner	18
12	Inflammatory bowel disease-attributable costs and cost-effective strategies in the United States 2010 ·Inflammatory Bowel Diseases ·K T Park, Dorsey Bass	110

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact